In this section

Receptor tyrosine kinase co-amplification and benefit from HER2 inhibitors in biliary tract cancers

Casolino, R., Amato, F., Rae, C. , Puttagunta, S. and Braconi, C. (2022) Receptor tyrosine kinase co-amplification and benefit from HER2 inhibitors in biliary tract cancers. Journal of Hepatology, 76(5), pp. 1227-1229. (doi: 10.1016/j.jhep.2022.01.012) (PMID:35093472)

[img] Text
262962.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
3MB

Abstract

No abstract available.

Item Type:Articles (Letter)
Additional Information:This study has been supported by the Lord Kelvin Adam Smith readership (University Of Glasgow), the ISSF Excellence and Innovation Catalyst award (Wellcome Trust), and the COST-ACTION-18122 (Euro-Cholangio-Net).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Puttagunta, Dr Srikanth and Rae, Dr Colin and Amato, Francesco and Braconi, Professor Chiara and Casolino, Dr Raffaella
Authors: Casolino, R., Amato, F., Rae, C., Puttagunta, S., and Braconi, C.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Journal of Hepatology
Publisher:Elsevier
ISSN:0168-8278
ISSN (Online):1600-0641
Published Online:27 January 2022
Copyright Holders:Copyright © 2022 European Association for the Study of the Liver
First Published:First published in Journal of Hepatology 76(5): 1227-1229
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details